Nanalysis Financial Statements From 2010 to 2024

NSCIF Stock  USD 0.27  0.01  3.85%   
Nanalysis Scientific financial statements provide useful quarterly and yearly information to potential Nanalysis Scientific Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nanalysis Scientific financial statements helps investors assess Nanalysis Scientific's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nanalysis Scientific's valuation are summarized below:
Nanalysis Scientific Corp does not presently have any fundamental ratios for analysis.
Check Nanalysis Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanalysis Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanalysis financial statements analysis is a perfect complement when working with Nanalysis Scientific Valuation or Volatility modules.
  
This module can also supplement various Nanalysis Scientific Technical models . Check out the analysis of Nanalysis Scientific Correlation against competitors.

Nanalysis Scientific Corp OTC Stock Return On Equity Analysis

Nanalysis Scientific's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Nanalysis Scientific Return On Equity

    
  -0.2  
Most of Nanalysis Scientific's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanalysis Scientific Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Nanalysis Scientific Corp has a Return On Equity of -0.197. This is 98.36% lower than that of the Technology sector and 128.14% lower than that of the Scientific & Technical Instruments industry. The return on equity for all United States stocks is 36.45% lower than that of the firm.

Nanalysis Scientific Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nanalysis Scientific's current stock value. Our valuation model uses many indicators to compare Nanalysis Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanalysis Scientific competition to find correlations between indicators driving Nanalysis Scientific's intrinsic value. More Info.
Nanalysis Scientific Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nanalysis Scientific's earnings, one of the primary drivers of an investment's value.

About Nanalysis Scientific Financial Statements

Nanalysis Scientific stakeholders use historical fundamental indicators, such as Nanalysis Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Nanalysis Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nanalysis Scientific's assets and liabilities are reflected in the revenues and expenses on Nanalysis Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nanalysis Scientific Corp. Please read more on our technical analysis and fundamental analysis pages.
Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It sells its products directly, as well as through a network of distributors worldwide. NANALYSIS SCIENTIFIC operates under Scientific Technical Instruments classification in the United States and is traded on OTC Exchange. It employs 107 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Nanalysis OTC Stock

Nanalysis Scientific financial ratios help investors to determine whether Nanalysis OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanalysis with respect to the benefits of owning Nanalysis Scientific security.